Effects of anandamide on polyamine levels and cell growth in human colon cancer cells

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2583-2589

  Linsalata, Michele ^a   Notarnicola, Maria ^a   Tutino, Valeria ^a   Bifulco, Maurizio ^b   Santoro, Antonietta ^b   Laezza, Chiara ^c,d   Messa, Caterina ^a   Orlando, Antonella ^a   Caruso, Maria Gabriella ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Anandamide; Cell growth; Colorectal cancer; Polyamines

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; MESSENGER RNA; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE; SR 1411716 A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INHIBITION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ARACHIDONIC ACIDS; BIOGENIC POLYAMINES; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HT29 CELLS; HUMANS; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER;

EID: 77955807756     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Joseph J, Niggermann B, Zaenker KS and Entschladen F: Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother 53: 723-728, 2004. (Pubitemid 38962066)
2. Pertwee RG and Ross RA: Cannabinoid receptors and their ligands. Prost Leukotr Essent Fatty Acids 66: 101-121, 2002.
3. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990. (Pubitemid 20238806)
4. Pertwee RG: Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6: 635-664, 1999.
5. Sliptetz DM, O'Neill GP, Favreau L, Dufresne C, Gallant M, Gareau Y, Guay D, Labelle M and Metters KM: Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharnacol 48: 352-361, 1995.
6. Derocq J-M, Bouaboula M, Marchand J, Rinaldi-Carmona M, Segui M and Casellas P: The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett 425: 419-425, 1998. (Pubitemid 28178844)
7. Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM and Becker GW: Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393: 231-235, 1996. (Pubitemid 26298102)
8. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D'Argenio G, Scaglione G, Bifulco M, Sorrentini I and Di Marzo V: Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125: 677-687, 2003. (Pubitemid 37070686)
9. Pisanti S, Borselli C, Oliviero O, Laezza C, Gazzerro P and Bifulco M: Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. J Cell Physiol 211: 495-503, 2007. (Pubitemid 46580103)
10. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M and Di Marzo V: The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 95: 8375-8380, 1998. (Pubitemid 28326120)
11. Notarnicola M, Messa C, Orlando A, Bifulco M, Laezza C, Gazzerro P and Caruso MG: Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. Scand J Gastroenterol 42: 1-7, 2007.
12. Tabor CW and Tabor H: Polyamines Annu Rev Biochem 53: 749-790, 1984.
13. Thomas T and Thomas TJ: Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58: 244-258, 2001. (Pubitemid 32217356)
14. Seiler N: Polyamine metabolism. Digestion 46: 319-330, 1990.
15. Bachrach U: Polyamines and neoplastic transformation. In: Polyamines in Cancer: Basic Mechanisms and Clinical Approaches. Nishioka K (eds.). Austin TX: RG Landes Co., pp. 45-74, 1996.
16. Linsalata M, Caruso MG, Leo S, Guerra V, D'Attoma B and Di Leo A: Prognostic value of tissue polyamine levels in human colorectal carcinoma. Anticancer Res 22: 2465-2470, 2002.
17. Fride E: The endocannabinoid CB receptor system: importance for development and in pediatric disease. Neuroendocrinol Lett 25: 25-30, 2004.
18. Williams CM and Kirkham TC: Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 143: 315-317, 1999.
19. Patsos HA, Hicks DJ, Greenhough A, Williams AC and Paraskeva C: Cannabinoids and cancer: potential for colorectal cancer therapy. Biochem Soc Trans 33: 712-714, 2005. (Pubitemid 41160846)
20. Bifulco M, Laezza C, Portella G, Vitale M, Orlando P, De Petrocellis L and Di Marzo: Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J 15: 2745-2747, 2005.
21. De Petrocellis L, Melck D, Bisogno T and Di Marzo V: Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. Chem Phys Lipids 108: 191-209, 2000.
22. Galve-Roperh I, Sanchez C, Cortes ML, del Pulsar TG, Izquierdo M and Guzman M: Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6: 313-319, 2000. (Pubitemid 30148624)
23. Wallace HM and Fraser AV: Inhibitors of polyamine metabolism: review article. Amino Acids 26: 353-365, 2004.
24. Linsalata M and Russo F: Nutritional factors and polyamine metabolism in colorectal cancer. Nutrition 24: 382-389, 2008.
25. Orlando A, Messa C, Linsalata M, Cavallini A and Russo F: Effect of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol Immunotoxicol 31(1): 108-16, 2009.
26. Gerner EW and Meyskens FL: Polyamines and cancer: old molecules, new understanding. Nature Rev 4: 781-792, 2004. (Pubitemid 39331150)
27. Pegg AE: Polyamine metabolism and its importance in neoplastic growth as a target for chemotherapy. Cancer Res 48: 759-774, 1988.
28. Wan H, Williams R, Doherty P and Williams F: A study of the reproducibility of the MTT test. J Mat Sci Mat Med 5: 154-159, 1994.
29. Alpini G and De Morrow S: Changes in the endocannabinoid system may give insight into new and effective treatment for cancer. Vitam Horm 81: 469-485, 2009.